KYORIN Pharmaceutical Co., Ltd.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (5)
Compared with Healthcare companies in Japan.
P/E ratio
29.4Investors pay 29.4 for every 1 of KYORIN Pharmaceutical Co., Ltd.'s yearly profit, higher than 88% of Healthcare companies in Japan.
P/B ratio
0.45The share price is 0.45 times KYORIN Pharmaceutical Co., Ltd.'s book value per share, lower than 98% of Healthcare companies in Japan.
Market cap
¥63.8 BThe total market value of all of KYORIN Pharmaceutical Co., Ltd.'s shares at today's price (share price × number of shares), smaller than 67% of Healthcare companies in Japan. PosiCap size class: Mini Cap.
Return on equity (ROE)
1.6%KYORIN Pharmaceutical Co., Ltd. earned 1.6% on its shareholders' money over the last year, lower than 92% of Healthcare companies in Japan.
Dividend yield
4.15%KYORIN Pharmaceutical Co., Ltd. pays 4.15% of its share price as dividends a year, higher than 90% of dividend-paying Healthcare companies in Japan.
Questions
What is KYORIN Pharmaceutical Co., Ltd.'s P/E ratio?
Investors pay 29.4 for every 1 of KYORIN Pharmaceutical Co., Ltd.'s yearly profit, higher than 88% of Healthcare companies in Japan.
What is KYORIN Pharmaceutical Co., Ltd.'s return on equity?
KYORIN Pharmaceutical Co., Ltd. earned 1.6% on its shareholders' money over the last year, lower than 92% of Healthcare companies in Japan.
Does KYORIN Pharmaceutical Co., Ltd. pay a dividend?
Yes. KYORIN Pharmaceutical Co., Ltd. pays 4.15% of its share price as dividends a year, higher than 90% of dividend-paying Healthcare companies in Japan.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.